Companies /Healthcare

BioLineRx Ltd

NASDAQ: BLRX Biotechnology
$2.65
▼ $0.11 (−3.99%) today
Markets open · 1:04pm ET
Today · % change

Fundamentals

Market Cap
$12.1M
Revenue (TTM)
$1.4M
52-Week Range
$2 – $5
Street Target
$23.00

About BioLineRx

BioLineRx Ltd., a clinical-stage biopharmaceutical development company, focuses on oncology. The company is headquartered in Hevel Modi'in, Israel.

BLRX Coverage